Ameriprise’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Buy |
|
|||||
|
2025
Q1 | $100M | Buy |
|
|||||
|
2024
Q4 | $113M | Buy |
|
|||||
|
2024
Q3 | $143M | Buy |
|
|||||
|
2024
Q2 | $157M | Sell |
|
|||||
|
2024
Q1 | $141M | Buy |
|
|||||
|
2023
Q4 | $110M | Sell |
|
|||||
|
2023
Q3 | $97.6M | Buy |
|
|||||
|
2023
Q2 | $80.2M | Buy |
|
|||||
|
2023
Q1 | $71.5M | Sell |
|
|||||
|
2022
Q4 | $63.7M | Sell |
|
|||||
|
2022
Q3 | $47.2M | Sell |
|
|||||
|
2022
Q2 | $65.2M | Sell |
|
|||||
|
2022
Q1 | $91.4M | Sell |
|
|||||
|
2021
Q4 | $93.2M | Sell |
|
|||||
|
2021
Q3 | $82.2M | Sell |
|
|||||
|
2021
Q2 | $80.6M | Buy |
|
|||||
|
2021
Q1 | $62.7M | Buy |
|
|||||
|
2020
Q4 | $64M | Buy |
|
|||||
|
2020
Q3 | $62.7M | Buy |
|
|||||
|
2020
Q2 | $46.1M | Sell |
|
|||||
|
2020
Q1 | $82.5M | Sell |
|
|||||
|
2019
Q4 | $110M | Sell |
|
|||||
|
2019
Q3 | $98.5M | Sell |
|
|||||
|
2019
Q2 | $101M | Sell |
|
|||||
|
2019
Q1 | $109M | Sell |
|
|||||
|
2018
Q4 | $104M | Buy |
|
|||||
|
2018
Q3 | $105M | Sell |
|
|||||
|
2018
Q2 | $109M | Buy |
|
|||||
|
2018
Q1 | $111M | Sell |
|
|||||
|
2017
Q4 | $131M | Sell |
|
|||||
|
2017
Q3 | $124M | Sell |
|
|||||
|
2017
Q2 | $113M | Sell |
|
|||||
|
2017
Q1 | $105M | Sell |
|
|||||
|
2016
Q4 | $177M | Buy |
|
|||||
|
2016
Q3 | $172M | Sell |
|
|||||
|
2016
Q2 | $581M | Sell |
|
|||||
|
2016
Q1 | $591M | Buy |
|
|||||
|
2015
Q4 | $599M | Buy |
|
|||||
|
2015
Q3 | $542M | Buy |
|
|||||
|
2015
Q2 | $450M | Buy |
|
|||||
|
2015
Q1 | $270M | Buy |
|
|||||
|
2014
Q4 | $46.5M | Buy |
|
|||||
|
2014
Q3 | $39.2M | Buy |
|
|||||
|
2014
Q2 | $37.7M | Buy |
|
|||||
|
2014
Q1 | $33.8M | Buy |
|
|||||
|
2013
Q4 | $3.43M | Sell |
|
|||||
|
2013
Q3 | $202M | Sell |
|
|||||
|
2013
Q2 | $187M | Buy |
|